Current Brachytherapy News and Events | Page 2

Current Brachytherapy News and Events, Brachytherapy News Articles.
Sort By: Most Relevant | Most Viewed
Page 2 of 6 | 224 Results
Mastectomy and reconstruction has higher complication rates, costs than lumpectomy and radiation
Among the various guideline-concordant local therapy options available for women with early-stage breast cancer in the United States, mastectomy plus reconstruction had the highest complication rates and complication-related costs for both younger women with private insurance and older women on Medicare, and it was the most expensive option for younger women, according to data presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12. (2015-12-10)

UCLA researchers find a wide variation in costs to treat low-risk prostate cancer
Now, for the first time, UCLA researchers have described cost across an entire care process for low-risk prostate cancer -- from the time a patient checks in for his first appointment to his post-treatment follow-up testing -- using time-driven activity-based costing. (2015-11-02)

Future Oncology 10th anniversary SFI celebrates the past, present and future in cancer
Future Oncology is celebrating its tenth anniversary by publishing a Special Focus issue documenting the past, present and future of several cancers. (2015-10-08)

Permanent radiotherapy implants reduce risk of prostate cancer recurrence after 5 years
Results from a randomized controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later. The research will be presented at the 3rd ESTRO Forum in Barcelona, Spain. (2015-04-26)

Brachytherapy improves survival for inoperable early stage endometrial cancer
Women who have early stage endometrial cancer and are inoperable tend to live longer if they have been treated with brachytherapy with or without external beam radiation, according to new research to be presented at the 3rd ESTRO Forum in Barcelona, Spain. (2015-04-25)

Combined brachytherapy techniques should be 'benchmark' for cervical cancer treatment
The first large international study to investigate the late side-effects of a combination of two forms of brachytherapy to treat cervical cancer has shown that the technique successfully delivers higher radiation doses to the tumor without an increase in treatment-related problems afterwards. The presentation at the 3rd Forum of the European Society for Radiotherapy and Oncology (ESTRO) in Barcelona suggests that the technique should be the 'benchmark' for treatment of the disease. (2015-04-24)

Theodorescu receives prestigious Barringer Medal
CU Cancer Center Director, Dan Theodorescu, M.D., Ph.D., earns the Barringer Medal from the American Association of Genitourinary Surgeons. (2015-04-24)

BWH study provides evidence for new approaches to prostate cancer
According to the results of a new study conducted at Brigham and Women's Hospital, there is evidence to also support AS as an initial approach for men with favorable intermediate-risk of PC (men with no evidence of the cancer spreading beyond the prostate, a Gleason score of 3+4 or less and PSA, prostate-specific antigen, under 20). (2015-02-19)

Proton therapy shown to be less costly than some alternative radiotherapy techniques
In terms of duration of treatment and cost, patients with early stage breast cancer may benefit from accelerated partial breast irradiation with proton therapy versus whole breast irradiation, according to new research from The University of Texas MD Anderson Proton Therapy Center. (2014-10-31)

Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function
A comparison of five-year sexual function outcomes, as reported by patients treated with external beam radiotherapy versus combination external beam radiotherapy plus brachytherapy, indicates that the utilization of vessel-sparing radiation therapy makes cure possible without compromising long-term sexual function, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (2014-09-16)

Special edition of the Red Journal highlights the need for radiation oncology services in LMICs
The July 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics, the official scientific journal of the American Society for Radiation Oncology, features a special section of 10 articles focusing on global health and radiation oncology in low- and middle-income countries. (2014-06-25)

Poor QOL doesn't predict low survival in high-risk lung cancer patients undergoing surgery
High-risk operable lung cancer patients have poorer quality of life scores than the normal US population. However surgery can still be undertaken safely: Low global quality of life scores were not associated with lower survival, recurrence-free rate, or for higher risk for adverse events following sublobar resection, a major surgical procedure. (2014-04-29)

ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer
The American Society for Radiation Oncology (ASTRO) has issued a new guideline, 'The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline,' that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. (2014-04-23)

Brachytherapy helps maintain erectile function in prostate cancer patients without compromising treatment outcomes
The use of permanent brachytherapy, a procedure where radioactive sources are placed inside the prostate, into or near to the tumor, preserves erectile function in approximately 50 percent of patients with prostate cancer. Brachytherapy used alone is as effective as other established therapies for localized low to intermediate risk prostate cancer. (2014-04-04)

Medication does not help prevent ED following radiation therapy for prostate cancer
Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a study in the April 2 issue of JAMA. (2014-04-01)

ASTRO white paper provides guidance for optimal quality, safety of HDR brachytherapy
The American Society for Radiation Oncology has issued a new white paper, 'A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy,' that recommends specific guidance to follow in the delivery of high-dose-rate brachytherapy to improve quality and patient safety, according to the manuscript published in the March-April 2014 print issue of Practical Radiation Oncology, the official clinical practice journal of ASTRO. (2014-03-05)

Reliable pretreatment information assists prostate cancer patients in decision-making
Men who have been diagnosed with prostate cancer need to assimilate information rapidly in order to weigh the treatment options and make informed decisions. Although patients consult a variety of information sources, outcome information that is specific to the treating physician leads to greater patient satisfaction following treatment, according to a new study published in The Journal of Urology®. (2014-03-03)

ESTRO 33
What is ESTRO 33? ESTRO 33 will feature new research results in clinical radiation oncology, radiobiology, physics, technology, and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients. The conference is expected to attract 3700 delegates from more than 80 countries. (2014-01-30)

Study finds brachytherapy offers lower rate of breast preservation compared to standard radiation for older women with breast cancer
When comparing treatments designed to enable long-term breast preservation for older women with invasive breast cancer, researchers found those treated with brachytherapy were at higher risk for a later mastectomy, compared to women treated with standard radiation therapy. The research was led by The University of Texas MD Anderson Cancer Center. (2014-01-30)

Extended outcomes from APBI show tumor control, breast cosmesis and minimal late toxicity
Long-term (five-year) outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation (APBI) after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study published in the Feb. 1, 2014, print edition of the International Journal of Radiation Oncology*Biology*Physics, the official scientific journal of the American Society for Radiation Oncology. (2014-01-29)

EBRT reduces risk of subsequent mastectomy in patients with invasive breast cancer
Standard external beam radiation therapy (EBRT) provided a higher breast preservation rate than brachytherapy in women age 66 and older with invasive breast cancer, according to a study published in the Feb. 1, 2014, print edition of the International Journal of Radiation Oncology*Biology*Physics, the official scientific journal of the American Society for Radiation Oncology. (2014-01-29)

Patients receiving ADT should be counseled to improve mental and emotional well-being
A new study published in the Journal of Urology reports that prostate cancer patients treated with androgen deprivation therapy (ADT) experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life two years after treatment. Investigators at the University of California-San Francisco recommend counseling men about the potential adverse effects of ADT as well as the interventions to improve mental and emotional health such as exercise programs and diet. (2014-01-23)

New 'Smart Rounds' improves safety of radiation therapy
A North Shore-LIJ researcher will present program outcomes at ASTRO's 55th Annual Meeting. (2013-09-25)

Cisplatin combined with high-dose brachytherapy for advanced cervical cancer may be more beneficial
Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy and high-dose-rate brachytherapy for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology's 55th Annual Meeting. The study also indicated that the combined treatments produced acceptable levels of toxicity. (2013-09-22)

Brachytherapy to treat cervical cancer declines in US, treatment associated with higher survival
A study by researchers at Brigham and Women's Hospital found that brachytherapy treatment was associated with better cause-specific survival and overall survival in women with cervical cancer. The population-based analysis also revealed geographic disparities and decline in brachytherapy treatment in the United States. (2013-09-11)

Observation is safe, cost-saving in low-risk prostate cancer
Dana-Farber researchers find many men with low-risk, localized prostate cancers can safely choose observation instead of undergoing immediate treatment and a have better quality of life while reducing health care costs. (2013-06-17)

2 landmark studies report on success of using image-guided brachytherapy to treat cervical cancer
Two large, landmark radiotherapy studies have shown that it is possible to treat cervical cancer effectively with high doses specifically adapted to each tumor, and with fewer serious side-effects to the surrounding normal organs. In two presentations on Saturday and Sunday researchers will tell the 2nd Forum of the European Society for Radiotherapy and Oncology that image-guided brachytherapy is able to deliver very high doses, which prevent the tumor from growing in over 90 percent of patients, with few serious side-effects. (2013-04-20)

Invitation to the 2nd ESTRO Forum
The 2nd ESTRO Forum will feature new research results in clinical radiation oncology, radiobiology, physics, technology, and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients. (2013-02-04)

How prostate cancer therapies compare by cost and effectiveness
The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness is reported this week by a team of researchers at the University of California, San Francisco. (2013-01-04)

Potential new technique for anticancer radiotherapy could provide alternative to brachytherapy
New approach could be alternative to surgical implantation of radioactive (2012-11-15)

Drop in testosterone tied to prostate cancer recurrence
Men whose testosterone drops following radiation therapy for prostate cancer are more likely to experience a change in PSA levels that signals their cancer has returned, according to new research from Fox Chase Cancer Center. The findings will be presented on Oct. 29 at the American Society for Radiation Oncology's 54th Annual Meeting. (2012-10-28)

Older breast cancer patients see more complications with brachytherapy
The breast cancer treatment brachytherapy -- heralded for its low complication rates -- actually results in more complications than whole-breast radiation one year after treatment, Yale School of Medicine researchers report in the October issue of the Journal of Clinical Oncology. (2012-10-22)

Predicting erectile dysfunction from prostate cancer treatment
Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction following radiation therapy for prostate cancer, according to a study to be published online Sept. 27, 2012, in advance of the Oct. 1, 2012 print issue, in the International Journal of Radiation Oncology.Biology.Physics, the official scientific journal of the American Society for Radiation Oncology. (2012-09-27)

Researchers find risk markers for erectile dysfunction following radiation in prostate cancer
In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction in prostate cancer patients who were treated with radiation. (2012-09-27)

Novel radiation therapy safely treats prostate cancer and lowers the risk of recurrence
A recent Phase I/II clinical trial has shown that a new combination of radiation therapies developed at Virginia Commonwealth University Massey Cancer Center escalates radiation doses to safely and effectively treat prostate cancer and lower the risk of recurrence with minimal radiation exposure to nearby healthy tissue and organs. (2012-06-26)

Relief of urinary symptoms is an underappreciated benefit of early stage prostate cancer treatment
Treatment of early stage prostate cancer can also result in improved quality of life for a subgroup of men who suffer from lower urinary tract symptoms (LUTS), according to an abstract of a Beth Israel Deaconess Medical Center-led study presented to the American Urological Association. (2012-05-20)

Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer
Using a concentrated, highly targeted dose of radiation to the breast has equally good results as irradiating the whole area, with no adverse effects on survival and a much better cosmetic outcome, Hungarian researchers have found. Accelerated partial breast irradiation should be offered to many more early stage breast cancer patients, the researchers say. (2012-05-11)

Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
Patients with low haemoglobin levels in their tumors do not respond well to radiotherapy, but now Dutch researchers have found that combining accelerated radiotherapy with a mixture of carbon dioxide and oxygen and the vitamin nicotinamide can overcome this problem in head and neck cancer. Use of the combination treatment meant that the differences in outcome between patients with low haemoglobin levels and those with normal levels were no longer significant. (2012-05-10)

3-D image guided brachytherapy helps avoid hysterectomies for cervical cancer patients
Delivering radiotherapy directly to cancer of the cervix using 3-D imaging techniques is effective at controlling the return and spread of the disease and, in most cases, avoids the need for hysterectomies. Results of this technique are for superior to those from previous eras using different treatments, and it has fewer side effects, researchers will tell the World Congress of Brachytherapy on Thursday. (2012-05-10)

APBI associated with more mastectomies, toxicities, complications, compared to traditional radiation
Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation (WBI), according to researchers from the University of Texas MD Anderson Cancer Center. (2012-05-01)

Page 2 of 6 | 224 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.